Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Editor's Pick Experimental Therapeutics

Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans

Hanchen Li, Ambily Abraham, David Gazzola, Yan Hu, Gillian Beamer, Kelly Flanagan, Ernesto Soto, Florentina Rus, Zeynep Mirza, Austin Draper, Sridhar Vakalapudi, Cheryl Stockman, Perry Bain, Joseph F. Urban Jr., Gary R. Ostroff, Raffi V. Aroian
Hanchen Li
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ambily Abraham
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Gazzola
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Hu
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gillian Beamer
bDepartment of Infectious Disease and Global Health, Tufts University, North Grafton, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelly Flanagan
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernesto Soto
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florentina Rus
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeynep Mirza
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Austin Draper
cSynthetic Biomanufacturing Facility, Utah State University, Logan, Utah, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sridhar Vakalapudi
cSynthetic Biomanufacturing Facility, Utah State University, Logan, Utah, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl Stockman
dCummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Perry Bain
dCummings School of Veterinary Medicine at Tufts University, North Grafton, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph F. Urban Jr.
eUnited States Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Diet, Genomics, Immunology Laboratory, Beltsville, Maryland, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary R. Ostroff
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raffi V. Aroian
aProgram in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raffi V. Aroian
DOI: 10.1128/AAC.01469-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Effects of gamma irradiation on B. thuringiensis spore viability and Cry5B bioactivity. (A) Effect of 15 kGy of gamma irradiation on spore counts for two different Cry-deficient B. thuringiensis strains (4.D.8 and 4.D.9) transformed with a Cry5B-expressing plasmid. (B) Comparison of Cry5B efficacy expressed in 4.D.8 and 4.D.9 on C. elegans viability at 100 µg/ml before and after 15-kGy irradiation. Labels without “15 kGy” indicate non-gamma-irradiated samples.

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    BaCC (bacteria with cytosolic crystals) and IBaCC (Inactivated bacteria with cytosolic crystals). (A) spo0A-deficient B. thuringiensis cells expressing Cry5B from a vegetative promoter before (BaCC) and after (IBaCC) treatment with essential oil. Cry5B bipyramidal crystals (dark) are evident inside the bacteria pre- and posttreatment. Scale bars, 5 µm. (B) Protein gel showing Cry5B protein expressed in spo0A-deficient cells before and after essential oil treatment. (C) Spore counts from spo0A-deficient cells expressing Cry5B before and after essential oil treatment along with standard deviation (actual spore counts, 2.1 × 107 CFU/ml in BaCC and 0 CFU/ml in IBaCC).

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    Efficacy of IBaCC in vitro against nematodes. (A) C. elegans. (Left) Photos of C. elegans N2 exposed to various conditions (spore crystal lysate [SCL] and IBaCC; both 40 µg/ml Cry5B). Scale bar, 200 µm. C. elegans was treated with azide to immobilize them just prior to imaging. (Right) Viability of C. elegans glp-4(bn2) L4 hermaphrodites under various conditions (IBaCC, 29 µg/ml Cry5B). P value for comparison is from a one-tailed t test. (B) Hookworm larval development. Plotted are the numbers of L3i larvae that developed from 60 hookworm eggs within 7 days (A. ceylanicum, left; N. americanus, right). x axes indicate the concentrations of Cry5B for IBaCC (IBa, 0 ng/ml for all).

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    Impact of Cry5B IBaCC on adult hookworms in vitro. Adult hookworm motility over time at 5, 50, and 200 µg/ml Cry5B for A. ceylanicum adults (A) and N. americanus adults (B) in vitro averaged over three independent trials. In all figures, plots show averages and standard errors. (C) (Left) SDS-PAGE gel showing IBaCC before (IBaCC) and after (rhod-IBaCC) labeling with rhodamine. (Right) UV fluorescence image of same gel, showing predominant labeling of full-length Cry5B band for rhod-IBaCC. (D) Uptake of rhod-IBaCC. (Left) Bright-field image of IBaCC and rhodamine fluorescence image of adult hookworm fed IBaCC for 4 h. (Right) Bright-field image of rhod-IBaCC and rhodamine fluorescence image of adult hookworm fed rhod-IBaCC for 4 h. Uptake of rhodamine-labeled Cry5B crystals is evident.

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Efficacy of IBaCC produced in the laboratory in vivo against both human hookworm genera. (A) Shown are mean A. ceylanicum hookworm burdens (left) and fecal egg counts (right) in infected hamsters treated with water control, IBa, or IBaCC containing Cry5B. Here and in subsequent figures, error bars are standard errors. EPG, eggs per gram of feces. (B) Mean N. americanus hookworm burdens (left) and fecal egg counts (right) in infected hamsters treated with water control or IBaCC containing Cry5B.

  • FIG 6
    • Open in new tab
    • Download powerpoint
    FIG 6

    Efficacy of production facility IBaCC in vivo against A. ceylanicum hookworms. (A) Dose response of A. ceylanicum burdens (left) and fecal egg counts (right) in infected hamsters treated with water control or CMO-produced IBaCC containing Cry5B. (B) A. ceylanicum burdens (left) and fecal egg counts (right) in infected hamsters treated with water or CMO-produced 15 mg/kg Cry5B in IBaCC. EPG, eggs per gram of feces. P values for relevant comparisons are given.

  • FIG 7
    • Open in new tab
    • Download powerpoint
    FIG 7

    Fit-for-purpose formulation studies for Cry5B IBaCC. (A) Mean A. ceylanicum hookworm burdens (left) and fecal egg counts (right) in infected hamsters treated with water control, IBaCC, or IBaCC mixed with sodium bicarbonate. No cimetidine pregavage was used in these experiments. (B) Mean A. ceylanicum hookworm burdens (left) and fecal egg counts (right) in infected hamsters treated with water control, IBaCC, or the same batch of IBaCC freeze-dried (FD). P values for relevant comparisons are given.

  • FIG 8
    • Open in new tab
    • Download powerpoint
    FIG 8

    Confirmation of fit-for-purpose Cry5B IBaCC efficacy against a different, luminal feeding parasite in a second host. Mean H. polygyrus bakeri burdens (left) and fecal egg counts (right) in infected mice treated with water, sodium bicarbonate, or single-dose freeze-dried (FD) Cry5B IBaCC mixed with sodium bicarbonate. The FD-IBaCC used was an independent batch from that used for the data shown in Fig. 7.

Additional Files

  • Figures
  • Supplemental material

    • Supplemental file 1 -

      Supplemental Figures S1 and S2 and Tables S1 to S3

      PDF, 183K

PreviousNext
Back to top
Download PDF
Citation Tools
Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans
Hanchen Li, Ambily Abraham, David Gazzola, Yan Hu, Gillian Beamer, Kelly Flanagan, Ernesto Soto, Florentina Rus, Zeynep Mirza, Austin Draper, Sridhar Vakalapudi, Cheryl Stockman, Perry Bain, Joseph F. Urban Jr., Gary R. Ostroff, Raffi V. Aroian
Antimicrobial Agents and Chemotherapy Feb 2021, 65 (3) e01469-20; DOI: 10.1128/AAC.01469-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of Humans
Hanchen Li, Ambily Abraham, David Gazzola, Yan Hu, Gillian Beamer, Kelly Flanagan, Ernesto Soto, Florentina Rus, Zeynep Mirza, Austin Draper, Sridhar Vakalapudi, Cheryl Stockman, Perry Bain, Joseph F. Urban Jr., Gary R. Ostroff, Raffi V. Aroian
Antimicrobial Agents and Chemotherapy Feb 2021, 65 (3) e01469-20; DOI: 10.1128/AAC.01469-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bacillus thuringiensis
anthelmintic
crystal protein
gastrointestinal nematodes
helminths
hookworms
paraprobiotic
soil-transmitted helminths

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596